Budget impact analysis of universal rotavirus vaccination in the Local Health Unit 11 Empoli, Tuscany, Italy
- PMID: 26789991
- PMCID: PMC4718349
Budget impact analysis of universal rotavirus vaccination in the Local Health Unit 11 Empoli, Tuscany, Italy
Abstract
Background: Rotavirus (RV) infection is the first cause of acute viral gastroenteritis in children under five years of age all over the world; it mainly affects children between six and 24 months of age and can cause serious acute diarrhoea and dehydration. The aim of this study is to perform the budget impact analysis of universal rotavirus vaccination in the Local Health Unit (LHU) 11 Empoli, Tuscany, Italy.
Methods: An ad hoc mathematical simulation model was developed to evaluate the budget impact analysis of 5-years universal rotavirus vaccination. Particularly, incidence of rotavirus gastroenteritis (RVGE), hospitalizations, nosocomial diarrhoea, medical consultations, prescriptions and accesses to emergency department were taken into account in the analysis. The direct medical costs due to RV diarrhoea and the costs of vaccination campaign were considered as the main outcome measures in the study.
Results: The adoption of universal rotavirus vaccination campaign for five years in the LHU 11 Empoli would result in relevant savings due to the health cares avoided. These savings would overlapped the costs of vaccination yet from the second year after the introduction of vaccination. The saving for the Health Service would be 1.5 million Euro after five years of campaign.
Conclusions: Universal vaccination against rotavirus results clinically and economically favourable for both the Health Service and the Society perspectives.
Keywords: Budget impact; Rotavirus; Vaccination.
© Copyright by Pacini Editore SpA, Pisa, Italy.
Figures
Similar articles
-
[A full economic evaluation of extensive vaccination against rotavirus with RIX4414 vaccine at National and Regional level in Italy].Ann Ig. 2013 Jan-Feb;25(1):43-56. doi: 10.7416/ai.2013.1905. Ann Ig. 2013. PMID: 23435779 Italian.
-
Impact of five years of rotavirus vaccination in Finland - And the associated cost savings in secondary healthcare.Vaccine. 2017 Oct 9;35(42):5611-5617. doi: 10.1016/j.vaccine.2017.08.052. Vaccine. 2017. PMID: 28893475
-
Burden of paediatric rotavirus gastroenteritis and potential benefits of a universal rotavirus vaccination programme with RotaTeq in France.Vaccine. 2007 Aug 21;25(34):6348-58. doi: 10.1016/j.vaccine.2007.06.015. Epub 2007 Jun 29. Vaccine. 2007. PMID: 17629598
-
Epidemiology and prevention of rotavirus infection: an underestimated issue?J Matern Fetal Neonatal Med. 2011 Oct;24 Suppl 2:48-51. doi: 10.3109/14767058.2011.601920. J Matern Fetal Neonatal Med. 2011. PMID: 21749188 Review.
-
The unpredictable diversity of co-circulating rotavirus types in Europe and the possible impact of universal mass vaccination programmes on rotavirus genotype incidence.Vaccine. 2012 Jun 29;30(31):4596-605. doi: 10.1016/j.vaccine.2012.04.097. Epub 2012 May 10. Vaccine. 2012. PMID: 22579864 Review.
Cited by
-
Accounting for Adverse Events Following Immunization in Economic Evaluation: Systematic Review of Economic Evaluations of Pediatric Vaccines Against Pneumococcus, Rotavirus, Human Papillomavirus, Meningococcus and Measles-Mumps-Rubella-Varicella.Pharmacoeconomics. 2023 May;41(5):481-497. doi: 10.1007/s40273-023-01252-z. Epub 2023 Feb 21. Pharmacoeconomics. 2023. PMID: 36809673
-
Parents' insights after pediatric hospitalization due to rotavirus gastroenteritis in Italy.Hum Vaccin Immunother. 2017 Sep 2;13(9):2155-2159. doi: 10.1080/21645515.2017.1336271. Epub 2017 Jun 13. Hum Vaccin Immunother. 2017. PMID: 28609219 Free PMC article.
References
-
- Giaquinto C, Damme P, Huet F, et al. Reveal Study Group, author. Costs of community-acquired pediatric rotavirus gastroenteritis in 7 European countries: the REVEAL Study. J Infect Dis. 2007;195(Suppl 1):S36–S44. - PubMed
-
- Damme P, Giaquinto C, Huet F, et al. Reveal Study Group, author. Multicenter prospective study of the burden of rotavirus acute gastroenteritis in Europe, 2004-2005: the REVEAL study. J Infect Dis. 2007;195(Suppl 1):S4–S16. - PubMed
-
- Giaquinto C, Damme P, Huet F, et al. Reveal Study Group, author. Clinical consequences of rotavirus acute gastroenteritis in Europe, 2004-2005: the REVEAL study. Infect Dis. 2007;195(Suppl 1):S26–S35. - PubMed
-
- Leung Ak, Kellner Jd, Davies Hd. Rotavirus gastroenteritis. Adv Ther. 2005;22:476–487. - PubMed
-
- Bresee Js, Glass Ri, Ivanoff B, et al. Current status and future priorities for rotavirus vaccine development, evaluation and implementation in developing countries. Vaccine. 1999;17:2207–2222. - PubMed
LinkOut - more resources
Full Text Sources